The project could open new avenues in the research of psychiatric disease based on neurobiology, ELKH said.

ELKH consultant István Katona is partnering on the two-year project with ELKH research professor György Miklós Keserű. The two researchers recently started a review of cariprazine and published their first results in the journal Nature Communications.